The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)
- 1 November 1994
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 74 (9), 875-883
- https://doi.org/10.1016/0002-9149(94)90579-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- High-density lipoproteins and atherosclerosisCurrent Opinion in Lipidology, 1993
- The role of lipids and antioxidative factors for development of atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)The American Journal of Cardiology, 1993
- Correlation between computer-assisted femoral arteriography and physiological tests in hypercholesterolaemic patients: a methodological study with special reference to clinical trialsClinical Physiology and Functional Imaging, 1992
- Blood lipids and human coronary atherosclerosis regression: the angiographic evidenceCurrent Opinion in Lipidology, 1991
- Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol quantitative regression Swedish trial (PQRST): A status reportThe American Journal of Cardiology, 1988
- Compensatory Enlargement of Human Atherosclerotic Coronary ArteriesThe New England Journal of Medicine, 1987
- Effects of probucol on xanthomata regression in familial hypercholesterolemiaThe American Journal of Cardiology, 1986
- Cross-sectional area of the proximal portions of the three major epicardial coronary arteries in 98 necropsy patients with different coronary events. Relationship to heart weight, age and sex.Circulation, 1980
- The rate of atherosclerosis change during treatment of hyperlipoproteinemia.Circulation, 1978
- Lipoprotein fractionation.Journal of Clinical Pathology, 1973